Genmab’s Stellar Cancer-Drug Data Fuels Stock’s $10 Billion Week
It’s been a breakout week for Danish biotech Genmab A/S.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
More in Finance & Markets
Germany’s flash Q3 GDP growth remains 0.2%, beats 0.1% estimates
German preliminary Q3 Gross Domestic Product (GDP) data arrives at 0.2%, Federal Statistics Office of Germany showed. The growth rate was higher than 0.1% estimates, but slower than 0.3% in the…
Tantalizers’ profit nearly doubles on stronger sales, lower expenses
Tantalizers Plc nearly doubled its nine-month profit in 2026, as stronger sales, improved gross margins and lower administrative expenses helped
Solidcore founder Anne Mahlum plans enormous 10-bedroom ‘dream home’
Solidcore founder Anne Mahlum is thinking big for her next home—a sprawling, 10-bedroom property designed around entertaining, family life, and her love of staying in.
Why the Markets Don’t Care About the Midterms
Factors like inflation, interest rates, A.I. and the war with Iran are far more important, our columnist says.
Magna Announces Strong Third Quarter Results
Highlights(1) Delivered strong third-quarter 2026 results, reflecting continued productivity improvements and disciplined execution.